Article

Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancer

2021-11-05

Abstract excerpt

<title>Abstract</title> <p>Personalized neoantigen vaccines have shown strong immunogenicity in clinical trial, but still face various challenges in facilitating an efficient antitumour immune response. Here we prepared a personalized neoantigen nanovaccine (PNVAC) platform for adjuvant cancer immunotherapy. PNVAC triggered superior protective efficacy against tumor recurrence and promoted longer survival than fr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a39ce5eb-d3f8-56cb-a4b6-e8baf234df7f
DOI: 10.21203/rs.3.rs-952430/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric/gastroesophageal junction cancerDOI 10.21203/rs.3.rs-952430/v1Read

Personalized mRNA Vaccine Combined with PD-1 Inhibitor Therapy in a Patient with Advanced Esophageal Squamous Cell CarcinomaSemantic proximity Read

Neoantigen polypeptide vaccines induce effective antitumor response in colorectal cancerSemantic proximity Read

Engineering neoantigen vaccines to improve cancer personalized immunotherapySemantic proximity Read

Therapeutic Effects of a Neoantigen Vaccine With an Immune Checkpoint Inhibitor in a Cisplatin-Treated Mouse ModelSemantic proximity Read

Viral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trialSemantic proximity Read

A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard TreatmentSemantic proximity Read

Current Trends in Neoantigen-Based Cancer VaccinesSemantic proximity Read

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.Semantic proximity Read

mRNA vaccine–induced neoantigen-specific T cell immunity in patients with gastrointestinal cancerSemantic proximity Read

Tumor neoantigens: from basic research to clinical applicationsSemantic proximity Read

Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver MetastasesSemantic proximity Read

The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenicSemantic proximity Read